Impact of routine surveillance biopsy intensity on the diagnosis of moderate to severe cellular rejection and survival after pediatric heart transplantation
Pediatric Transplantation, EarlyView. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 29, 2018 Category: Transplant Surgery Source Type: research
A prospective randomized, controlled trial of eculizumab to prevent ischemia ‐reperfusion injury in pediatric kidney transplantation
Pediatric Transplantation,Volume 22, Issue 2, March 2018. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 29, 2018 Category: Transplant Surgery Source Type: research
Obesity class does not further stratify outcome in overweight and obese pediatric patients after heart transplantation
Pediatric Transplantation,Volume 22, Issue 2, March 2018. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 29, 2018 Category: Transplant Surgery Source Type: research
---
Pediatric Transplantation, Ahead of Print. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 29, 2018 Category: Transplant Surgery Source Type: research
---
Pediatric Transplantation,Volume 22, Issue 2, March 2018. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 29, 2018 Category: Transplant Surgery Source Type: research
Extracorporeal photopheresis as second ‐line treatment therapy in life‐threatening primary graft dysfunction following lung transplantation
Abstract
ECP is an established “second‐line” treatment for CLAD/BOS. Recently, ECP was used for the first time in an adolescent CF patient as a “second‐line” treatment therapy in life‐threatening primary graft dysfunction following lung transplantation who deteriorated despite extensive treatment including ECMO and ATG. Within 10 days after initiation of ECP twice weekly, allograft function and clinical status improved significantly and the patient was weaned from mechanical ventilation support. ECP has been continued every 2 weeks since. Two hundred days after lung transplantation, the patient has an accep...
Source: Pediatric Transplantation - January 29, 2018 Category: Transplant Surgery Authors: C écile A Robinson, Ilhan Inci, Mirjam Naegeli, Christian Murer, Macé M Schuurmans, Mirjana Urosevic‐Maiwald, Reto Schüpbach, Walter Weder, Christian Benden Tags: CASE REPORT Source Type: research
Impact of routine surveillance biopsy intensity on the diagnosis of moderate to severe cellular rejection and survival after pediatric heart transplantation
Abstract
Data are lacking on RSB intensity and outcomes after pediatric heart transplantation. PHTS centers received a survey on RSB practices from 2005 to present. PHTS data were obtained for 2010‐2013 and integrated with center‐matched survey responses for analysis. Survey response rate was 82.6% (38/46). Centers were classified as low‐, moderate‐, and high‐intensity programs based on RSB frequency (0—more than 8 RSB/y). RSB intensity decreased with increasing time from HT. Age at HT impacted RSB intensity mostly in year 1, with little to no impact in later years. Most centers have not replaced RSB with non...
Source: Pediatric Transplantation - January 29, 2018 Category: Transplant Surgery Authors: Matthew D. Zinn, Michael J. Wallendorf, Kathleen E. Simpson, Ashley D. Osborne, James K. Kirklin, Charles E. Canter Tags: ORIGINAL ARTICLE Source Type: research
A prospective randomized, controlled trial of eculizumab to prevent ischemia ‐reperfusion injury in pediatric kidney transplantation
Abstract
Ischemia‐reperfusion injury has multiple effects on a transplanted allograft, including delayed or impaired graft function, compromised long‐term survival, and an association with an increased incidence of rejection. Eculizumab, a monoclonal antibody blocking terminal complement activation, has been postulated to be an effective agent in the prevention or amelioration of IRI. We performed a single‐center prospective, randomized controlled trial involving 57 pediatric kidney transplant recipients between 2012 and 2016. The immunosuppressive protocol included two doses of alemtuzumab; half of the patients were...
Source: Pediatric Transplantation - January 29, 2018 Category: Transplant Surgery Authors: Michael Kaabak, Nadeen Babenko, Ron Shapiro, Allan Zokoyev, Olga Dymova, Edward Kim Tags: ORIGINAL ARTICLE Source Type: research
Transient elastography for non ‐invasive evaluation of post‐transplant liver graft fibrosis in children
Pediatric Transplantation,Volume 22, Issue 2, March 2018. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 25, 2018 Category: Transplant Surgery Source Type: research
---
Pediatric Transplantation,Volume 22, Issue 2, March 2018. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 25, 2018 Category: Transplant Surgery Source Type: research
Obliterative portal venopathy: A histopathologic finding associated with chronic antibody ‐mediated rejection in pediatric liver allografts
Pediatric Transplantation,Volume 22, Issue 2, March 2018. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 24, 2018 Category: Transplant Surgery Source Type: research
---
Pediatric Transplantation,Volume 22, Issue 2, March 2018. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 24, 2018 Category: Transplant Surgery Source Type: research
Effects of iron and vitamin B12 deficiencies on peripheral blood colony ‐forming unit capacity
Pediatric Transplantation, EarlyView. (Source: Pediatric Transplantation)
Source: Pediatric Transplantation - January 22, 2018 Category: Transplant Surgery Source Type: research
